Clinical trial
Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With…
NCT00387790 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00387790 |
|---|---|
| Title | Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma |
| Official title | A Phase II Study of Motexafin-Gadolinium (NSC 695238, IND #55583) and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Untreated Childhood Brain Stem Glioma |
| Intervention type | Drug, Radiation |
| Interventions | motexafin gadolinium, 3-dimensional conformal radiation therapy |
| Enrollment | 64 |
| Start date | Jun 1, 2007 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Oct 13, 2006 |
| Last update posted | Jan 4, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: